Oxycodone and Acetaminophen Capsules, USP 5mg/500 mg, packaged in a)100-count bottle (NDC 0591-07...
FDA Drug Recall #D-823-2013 — Class III — July 19, 2013
Recall Summary
| Recall Number | D-823-2013 |
| Classification | Class III — Low risk |
| Date Initiated | July 19, 2013 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Watson Laboratories Inc |
| Location | Corona, CA |
| Product Type | Drugs |
| Quantity | 1,260 bottles |
Product Description
Oxycodone and Acetaminophen Capsules, USP 5mg/500 mg, packaged in a)100-count bottle (NDC 0591-0737-01), b) 500-count bottle (NDC 0591-0737-05), Rx only, Manufactured by Watson Laboratories, Inc., Corona, CA92880.
Reason for Recall
Subpotent drug: Two lots of Oxycodone and Acetaminophen Capsules, USP 5/500 mg are being recalled due to low out of specification (OOS) assay result obtained at expiry (24 months) for the oxycodone portion of the product.
Distribution Pattern
Nationwide
Lot / Code Information
Lot # a) 444971A, Exp 8/13; b) 444973A, Exp 8/13
Other Recalls from Watson Laboratories Inc
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-1053-2014 | Class II | Hydrocodone Bitartrate and Acetaminophen Tablet... | Jan 15, 2014 |
| D-397-2014 | Class II | Carisoprodol Tablets, USP, CIV, 350 mg, 500 cou... | Dec 23, 2013 |
| D-66360-001 | Class II | Next Choice" One Dose Emergency Contraceptive (... | Sep 23, 2013 |
| D-66251-001 | Class II | Oxycodone and Acetaminophen Tablets, USP 10 mg/... | Sep 13, 2013 |
| D-1061-2013 | Class III | Hydrocodone Bitartrate and Acetaminophen Tablet... | Aug 30, 2013 |
Frequently Asked Questions
Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.